Authors:
Druker, BJ
Talpaz, M
Resta, DJ
Peng, B
Buchdunger, E
Ford, JM
Lydon, NB
Kantarjian, H
Capdeville, R
Ohno-Jones, S
Sawyers, CL
Citation: Bj. Druker et al., Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinasein chronic myeloid leukemia., N ENG J MED, 344(14), 2001, pp. 1031-1037
Authors:
Buchdunger, E
Cioffi, CL
Law, N
Stover, D
Ohno-Jones, S
Druker, BJ
Lydon, NB
Citation: E. Buchdunger et al., Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-Kit and platelet-derived growth factor receptors, J PHARM EXP, 295(1), 2000, pp. 139-145
Citation: Bj. Druker et Nb. Lydon, Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia, J CLIN INV, 105(1), 2000, pp. 3-7